Skip to main content
MITI
OTC Technology

Mitesco Issues 17.1M Shares to Insiders and Advisors, Diluting Existing Holders by ~57%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.035
Mkt Cap
$732.921K
52W Low
$0.027
52W High
$0.398
52W Position info
30% above low
Off High info
91% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

MITI sits 30% above its 52-week low of $0.027 on elevated volume (2.2× avg).

Summary

Mitesco authorized 17.1 million restricted shares to insiders and advisors, increasing outstanding shares by ~57% to 47 million. The issuance rewards board members, developers, and consultants amid a cash crisis, heavily diluting existing holders.


Key Events · Financing and Capital Events · MITI

  • 17.1M Shares Issued to Insiders

    Board authorized 17.1 million restricted shares to directors, developers, advisors, and a financial advisor, increasing outstanding shares from ~20.9M to ~47M — a 57% dilution.

  • Board Members Awarded 9M Shares

    Three board members each received 3,000,000 shares as compensation, totaling $315,000 in expense at $0.035/share.

  • Robo Agent Developers Get 3.1M Shares

    Four individuals responsible for the Robo Agent software received 3,100,000 shares as compensation, bringing their total holdings to 1,000,000 each.

  • Advisory Agreement with Dawson James

    Dawson James Securities engaged for advisory services, receiving 1,000,000 restricted shares; additional fees may apply for future financings or M&A.


Analysis · MITI · Technology

Mitesco authorized 17.1 million restricted shares to board members, developers, advisors, and a financial advisor — nearly doubling the share count from 20.9 million to about 47 million. The shares are priced at $0.035, the recent closing price, and total compensation expense of $738,500. This massive insider issuance comes amid a critical financial state with no revenue, minimal cash, and a going concern warning. While the shares are restricted and not immediately sold, the dilution is severe and signals the board is rewarding itself and key contributors with equity rather than cash, further pressuring existing shareholders. The advisory agreement with Dawson James may bring future financing but adds no immediate value.

At the time of this filing, MITI was trading at $0.04 on OTC in the Technology sector, with a market capitalization of approximately $732.9K. The 52-week trading range was $0.03 to $0.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MITI - Latest Insights

MITI
Jul 21, 2026, 5:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0975
Real-time Price: $0.035 info
Change: -$0.0625 (-64%) info
Market Cap: $732.921K info
MITI
Jul 09, 2026, 4:13 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.070
Real-time Price: $0.035 info
Change: -$0.035 (-50%) info
Market Cap: $732.921K info
MITI
Jul 02, 2026, 7:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.075468
Real-time Price: $0.035 info
Change: -$0.040468 (-54%) info
Market Cap: $732.921K info
MITI
Jun 30, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.073
Real-time Price: $0.035 info
Change: -$0.038 (-52%) info
Market Cap: $732.921K info
MITI
Jun 08, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.085
Real-time Price: $0.035 info
Change: -$0.050 (-59%) info
Market Cap: $732.921K info